23 / 27
A p r i l 2 2 - 2 3 , 2 0 1 9
A t h e n s , G r e e c e
Page 75
Archives of Clinical Microbiology
ISSN: 1989-8436
Virology and Infectious Diseases 2019
EuroSciCon Conference on
Virology and Infectious Diseases
Objective:
To obtain enough information about the prevalence of the ARV side effects in pregnant women infected with
HIV and their infants and also evaluate drug efficacy in decreasing HIV infection in their children.
Method:
This descriptive study was based on information of 40 pregnant women infected with HIV files at voluntary and
counseling center, Imam Khomeini Hospital, Tehran, Iran during 2009 -2013. In this study, we evaluated epidemiologic,
demographic, clinical, laboratory data and drugs side effects.
Results:
The most commonly used drug group was AZT/3TC/EFV. About 75.5% of patients received mother to child
prevention and 27.5% received ARV Antiretroviral therapy treatment. 5% anemia, 2.5% rash and 2.5% pre rupture of
membranes were reported and no preeclampsia or gestational diabetes was reported in patients’ files. Only one
abortion (2.5%) was occurred in late first trimester. Except rash, other adverse effects were solely reported in ARV
treatment group. All neonates had normal Apgar score. Fetal defects were not reported at birth.
Conclusion:
In this evaluation, safety of ARV in pregnancy period and at birth was observed especially in the group
received prevention of mother to child transmission (PMTCT). So we advise ARV treatment or PMTCT in pregnancy
period.
z.bayat.1355@gmail.comDrugs side effects in pregnant women infected
with HIV referred to Imam Khomeini Hospital,
voluntary counseling and Testing Center Tehran,
Iran 2009-2013
Zahra Bayat Jozani, Zohreh Rostam Afshar, Lila Taj and Minoo
Mohraz
Iranian Research Center of HIV/AIDS-Tehran University of Medical Sciences, Iran
Arch Clin Microbiol 2019, Volume:10
DOI: 10.4172/1989-8436-C1-018